|
1
|
Hensley ML, Barrette BA, Baumann K,
Gaffney D, Hamilton AL, Kim JW, Maenpaa JU, Pautier P, Siddiqui NA,
Westermann AM and Ray-Coquard I: Gynecologic cancer intergroup
(GCIG) consensus review: Uterine and ovarian leiomyosarcomas. Int J
Gynecol Cancer. 24 (Suppl 3):S61–S66. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Giuntoli RL II, Metzinger DS, DiMarco CS,
Cha SS, Sloan JA, Keeney GL and Gostout BS: Retrospective review of
208 patients with leiomyosarcoma of the uterus: Prognostic
indicators, surgical management, and adjuvant therapy. Gynecol
Oncol. 89:460–469. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kapp DS, Shin JY and Chan JK: Prognostic
factors and survival in 1,396 patients with uterine
leiomyosarcomas: Emphasis on impact of lymphadenectomy and
oophorectomy. Cancer. 112:820–830. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Abeler VM, Røyne O, Thoresen S, Danielsen
HE, Nesland JM and Kristensen GB: Uterine sarcomas in Norway. A
histopathological and prognostic survey of a total population from
1970 to 2000 including 419 patients. Histopathology. 54:355–364.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gockley AA, Rauh-Hain JA and del Carmen
MG: Uterine leiomyosarcoma: A review article. Int J Gynecol Cancer.
24:1538–1542. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Miller H, Ike C, Parma J, Masand RP, Mach
CM and Anderson ML: Molecular targets and emerging therapeutic
options for uterine leiomyosarcoma. Sarcoma. 2016:70181062016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Richardson HE, Stueland CS, Thomas J,
Russell P and Reed SI: Human cDNAs encoding homologs of the small
p34Cdc28/Cdc2-associated protein of Saccharomyces cerevisiae
and Schizosaccharomyces pombe. Genes Dev. 4:1332–1344. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ganoth D, Bornstein G, Ko TK, Larsen B,
Tyers M, Pagano M and Hershko A: The cell-cycle regulatory protein
Cks1 is required for SCF(Skp2)-mediated ubiquitinylation of p27.
Nat Cell Biol. 3:321–324. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Martinsson-Ahlzén HS, Liberal V,
Grünenfelder B, Chaves SR, Spruck CH and Reed SI: Cyclin-dependent
kinase-associated proteins Cks1 and Cks2 are essential during early
embryogenesis and for cell cycle progression in somatic cells. Mol
Cell Biol. 28:5698–5709. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Spruck CH, de Miguel MP, Smith AP, Ryan A,
Stein P, Schultz RM, Lincoln AJ, Donovan PJ and Reed SI:
Requirement of cks2 for the first metaphase/anaphase transition of
mammalian meiosis. Science. 300:647–650. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang J, Xu L, Liu Y, Chen J, Jiang H, Yang
S and Tan H: Expression of cyclin kinase subunit 2 in human breast
cancer and its prognostic significance. Int J Clin Exp Pathol.
7:8593–8601. 2014.PubMed/NCBI
|
|
12
|
Wang JJ, Fang ZX, Ye HM, You P, Cai MJ,
Duan HB, Wang F and Zhang ZY: Clinical significance of
overexpressed cyclin-dependent kinase subunits 1 and 2 in
esophageal carcinoma. Dis Esophagus. 26:729–736. 2013.PubMed/NCBI
|
|
13
|
Tanaka F, Matsuzaki S, Mimori K, Kita Y,
Inoue H and Mori M: Clinicopathological and biological significance
of CDC28 protein kinase regulatory subunit 2 overexpression in
human gastric cancer. Int J Oncol. 39:361–372. 2011.PubMed/NCBI
|
|
14
|
Yu MH, Luo Y, Qin SL, Wang ZS, Mu YF and
Zhong M: Up-regulated CKS2 promotes tumor progression and predicts
a poor prognosis in human colorectal cancer. Am J Cancer Res.
5:2708–2718. 2015.PubMed/NCBI
|
|
15
|
Shen DY, Fang ZX, You P, Liu PG, Wang F,
Huang CL, Yao XB, Chen ZX and Zhang ZY: Clinical significance and
expression of cyclin kinase subunits 1 and 2 in hepatocellular
carcinoma. Liver Int. 30:119–125. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shen DY, Zhan YH, Wang QM, Rui G and Zhang
ZM: Oncogenic potential of cyclin kinase subunit-2 in
cholangiocarcinoma. Liver Int. 33:137–148. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kawakami K, Enokida H, Tachiwada T,
Gotanda T, Tsuneyoshi K, Kubo H, Nishiyama K, Takiguchi M, Nakagawa
M and Seki N: Identification of differentially expressed genes in
human bladder cancer through genome-wide gene expression profiling.
Oncol Rep. 16:521–531. 2006.PubMed/NCBI
|
|
18
|
Walker RA: World Health Organization
classification of tumours. Pathology and genetics of tumours of the
breast and female genital organs. Histopathology. 46:229. 2005.
View Article : Google Scholar
|
|
19
|
Prat J: FIGO staging for uterine sarcomas.
Int J Gynaecol Obstet. 104:177–178. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Coley HM, Shotton CF, Kokkinos MI and
Thomas H: The effects of the CDK inhibitor seliciclib alone or in
combination with cisplatin in human uterine sarcoma cell lines.
Gynecol Oncol. 105:462–469. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Qi J, Yu Y, Akilli Öztürk Ö, Holland JD,
Besser D, Fritzmann J, Wulf-Goldenberg A, Eckert K, Fichtner I and
Birchmeier W: New Wnt/β-catenin target genes promote experimental
metastasis and migration of colorectal cancer cells through
different signals. Gut. 65:1690–1701. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cui RR, Wright JD and Hou JY: Uterine
leiomyosarcoma: A review of recent advances in molecular biology,
clinical management and outcome. BJOG. 124:1028–1037. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cuppens T, Tuyaerts S and Amant F:
Potential therapeutic targets in uterine sarcomas. Sarcoma.
2015:2432982015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Taylor BS, Barretina J, Maki RG, Antonescu
CR, Singer S and Ladanyi M: Advances in sarcoma genomics and new
therapeutic targets. Nat Rev Cancer. 11:541–557. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mäkinen N, Aavikko M, Heikkinen T, Taipale
M, Taipale J, Koivisto-Korander R, Bützow R and Vahteristo P: Exome
sequencing of uterine leiomyosarcomas identifies frequent mutations
in tp53, atrx, and med12. PLoS Genet. 12:e10058502016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
You H, Lin H and Zhang Z: CKS2 in human
cancers: Clinical roles and current perspectives (Review). Mol Clin
Oncol. 3:459–463. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Koivisto-Korander R, Martinsen JI,
Weiderpass E, Leminen A and Pukkala E: Incidence of uterine
leiomyosarcoma and endometrial stromal sarcoma in Nordic countries:
Results from NORDCAN and NOCCA databases. Maturitas. 72:56–60.
2012. View Article : Google Scholar : PubMed/NCBI
|
